Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus Maturation

Nelfinavir (NFV) is an HIV-1 aspartyl protease inhibitor that has numerous effects on human cells, which impart attractive antitumor properties. NFV has also been shown to have in vitro inhibitory activity against human herpesviruses (HHVs). Given the apparent absence of an aspartyl protease encoded...

Full description

Saved in:
Bibliographic Details
Main Authors: Soren Gantt, Eliora Gachelet, Jacquelyn Carlsson, Serge Barcy, Corey Casper, Michael Lagunoff
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Advances in Virology
Online Access:http://dx.doi.org/10.1155/2015/687162
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567773378641920
author Soren Gantt
Eliora Gachelet
Jacquelyn Carlsson
Serge Barcy
Corey Casper
Michael Lagunoff
author_facet Soren Gantt
Eliora Gachelet
Jacquelyn Carlsson
Serge Barcy
Corey Casper
Michael Lagunoff
author_sort Soren Gantt
collection DOAJ
description Nelfinavir (NFV) is an HIV-1 aspartyl protease inhibitor that has numerous effects on human cells, which impart attractive antitumor properties. NFV has also been shown to have in vitro inhibitory activity against human herpesviruses (HHVs). Given the apparent absence of an aspartyl protease encoded by HHVs, we investigated the mechanism of action of NFV herpes simplex virus type 1 (HSV-1) in cultured cells. Selection of HSV-1 resistance to NFV was not achieved despite multiple passages under drug pressure. NFV did not significantly affect the level of expression of late HSV-1 gene products. Normal numbers of viral particles appeared to be produced in NFV-treated cells by electron microscopy but remain within the cytoplasm more often than controls. NFV did not inhibit the activity of the HSV-1 serine protease nor could its antiviral activity be attributed to inhibition of Akt phosphorylation. NFV was found to decrease glycosylation of viral glycoproteins B and C and resulted in aberrant subcellular localization, consistent with induction of endoplasmic reticulum stress and the unfolded protein response by NFV. These results demonstrate that NFV causes alterations in HSV-1 glycoprotein maturation and egress and likely acts on one or more host cell functions that are important for HHV replication.
format Article
id doaj-art-06cc98f21b5d451b9a3e6219c6068d92
institution Kabale University
issn 1687-8639
1687-8647
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Advances in Virology
spelling doaj-art-06cc98f21b5d451b9a3e6219c6068d922025-02-03T01:00:34ZengWileyAdvances in Virology1687-86391687-86472015-01-01201510.1155/2015/687162687162Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus MaturationSoren Gantt0Eliora Gachelet1Jacquelyn Carlsson2Serge Barcy3Corey Casper4Michael Lagunoff5Seattle Children’s Research Institute, University of Washington, Seattle, WA 98101, USADepartment of Microbiology, University of Washington, Seattle, WA 98195, USADepartment of Medicine, University of Washington, Seattle, WA 98195, USASeattle Children’s Research Institute, University of Washington, Seattle, WA 98101, USADepartment of Global Health, University of Washington, Seattle, WA 98195, USADepartment of Microbiology, University of Washington, Seattle, WA 98195, USANelfinavir (NFV) is an HIV-1 aspartyl protease inhibitor that has numerous effects on human cells, which impart attractive antitumor properties. NFV has also been shown to have in vitro inhibitory activity against human herpesviruses (HHVs). Given the apparent absence of an aspartyl protease encoded by HHVs, we investigated the mechanism of action of NFV herpes simplex virus type 1 (HSV-1) in cultured cells. Selection of HSV-1 resistance to NFV was not achieved despite multiple passages under drug pressure. NFV did not significantly affect the level of expression of late HSV-1 gene products. Normal numbers of viral particles appeared to be produced in NFV-treated cells by electron microscopy but remain within the cytoplasm more often than controls. NFV did not inhibit the activity of the HSV-1 serine protease nor could its antiviral activity be attributed to inhibition of Akt phosphorylation. NFV was found to decrease glycosylation of viral glycoproteins B and C and resulted in aberrant subcellular localization, consistent with induction of endoplasmic reticulum stress and the unfolded protein response by NFV. These results demonstrate that NFV causes alterations in HSV-1 glycoprotein maturation and egress and likely acts on one or more host cell functions that are important for HHV replication.http://dx.doi.org/10.1155/2015/687162
spellingShingle Soren Gantt
Eliora Gachelet
Jacquelyn Carlsson
Serge Barcy
Corey Casper
Michael Lagunoff
Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus Maturation
Advances in Virology
title Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus Maturation
title_full Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus Maturation
title_fullStr Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus Maturation
title_full_unstemmed Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus Maturation
title_short Nelfinavir Impairs Glycosylation of Herpes Simplex Virus 1 Envelope Proteins and Blocks Virus Maturation
title_sort nelfinavir impairs glycosylation of herpes simplex virus 1 envelope proteins and blocks virus maturation
url http://dx.doi.org/10.1155/2015/687162
work_keys_str_mv AT sorengantt nelfinavirimpairsglycosylationofherpessimplexvirus1envelopeproteinsandblocksvirusmaturation
AT elioragachelet nelfinavirimpairsglycosylationofherpessimplexvirus1envelopeproteinsandblocksvirusmaturation
AT jacquelyncarlsson nelfinavirimpairsglycosylationofherpessimplexvirus1envelopeproteinsandblocksvirusmaturation
AT sergebarcy nelfinavirimpairsglycosylationofherpessimplexvirus1envelopeproteinsandblocksvirusmaturation
AT coreycasper nelfinavirimpairsglycosylationofherpessimplexvirus1envelopeproteinsandblocksvirusmaturation
AT michaellagunoff nelfinavirimpairsglycosylationofherpessimplexvirus1envelopeproteinsandblocksvirusmaturation